Nidhi Kaushal

发表

A Novel Set Level Technique for Image Segmentation Using Fuzzy Clustering and Self Organizing Map Network

R. S. Pippal, Nidhi Kaushal, Murlidhar Vishwakarma, 2015 .

Conversion of a highly selective sigma-1 receptor-ligand to sigma-2 receptor preferring ligands with anticocaine activity.

J. Poupaert, Yan-tong Xu, Nidhi Kaushal, 2008, Journal of medicinal chemistry.

A Novel Substituted Piperazine, CM156, Attenuates the Stimulant and Toxic Effects of Cocaine in Mice

Yan-tong Xu, Nidhi Kaushal, C. McCurdy, 2010, Journal of Pharmacology and Experimental Therapeutics.

Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice

A. Coop, Nidhi Kaushal, J. Huber, 2011, Pharmacology Biochemistry and Behavior.

Role of Sigma Receptors in Methamphetamine-Induced Neurotoxicity

Nidhi Kaushal, R. Matsumoto, 2011, Current neuropharmacology.

Happiness at Work with Contentment: Enriching Workplace Well-Being Through Ancient Wisdom

Nidhi Kaushal, 2020, The Palgrave Handbook of Workplace Well-Being.

Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro.

Nidhi Kaushal, C. McCurdy, R. Matsumoto, 2014, European journal of pharmacology.

AC927, a σ Receptor Ligand, Blocks Methamphetamine-Induced Release of Dopamine and Generation of Reactive Oxygen Species in NG108-15 Cells

Y. Rojanasakul, A. Coop, Nidhi Kaushal, 2012, Molecular Pharmacology.

The evaluation of AZ66, an optimized sigma receptor antagonist, against methamphetamine-induced dopaminergic neurotoxicity and memory impairment in mice.

Rolf T Hansen, Han-Ting Zhang, Nidhi Kaushal, 2013, The international journal of neuropsychopharmacology.

CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice

Nidhi Kaushal, C. McCurdy, C. Mesangeau, 2011, Neuropharmacology.

Happiness at Work with Contentment: Enriching Workplace Well-Being Through Ancient Wisdom

Nidhi Kaushal, 2021, The Palgrave Handbook of Workplace Well-Being.

Comprehensive Interpretation of Leadership from the Narratives in Literature

Nidhi Kaushal, Sanjit Mishra, 2017 .

Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo

Nidhi Kaushal, C. McCurdy, R. Matsumoto, 2013, European Neuropsychopharmacology.

Balanced Activation of Striatal Output Pathways by Faster Off-Rate PDE10A Inhibitors Elicits Not Only Antipsychotic-Like Effects But Also Procognitive Effects in Rodents

Nidhi Kaushal, H. Kimura, Kazunori Suzuki, 2019, The international journal of neuropsychopharmacology.

Sigma receptors as potential therapeutic targets for neuroprotection.

Nidhi Kaushal, R. Matsumoto, M. Robson, 2014, European journal of pharmacology.

First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson's Disease: Discovery, Pharmacological Validation, and Identification of a Clinical Candidate.

H. Monenschein, S. Kikuchi, Nidhi Kaushal, 2021, Journal of medicinal chemistry.

Respect and Recognition of the Work as Building Blocks of the Workplace: A Work-Psychological Perspective

Nidhi Kaushal, 2020, The Palgrave Handbook of Workplace Well-Being.

Conceptualizing the Literary Study of Primal Ethics with Management

Nidhi Kaushal, Sanjit Mishra, 2017 .

AC927, a (cid:1) Receptor Ligand, Blocks Methamphetamine-Induced Release of Dopamine and Generation of Reactive Oxygen Species in NG108-15 Cells

Y. Rojanasakul, A. Coop, Nidhi Kaushal, 2012 .

Generation of Reactive Oxygen Species in NG108-15 Cells

A. Coop, Nidhi Kaushal, A. Iyer, 2011 .

Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.

B. Lucke-Wold, Nidhi Kaushal, R. Matsumoto, 2017, Advances in experimental medicine and biology.

Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects.

Nidhi Kaushal, R. Matsumoto, M. Robson, 2014, Advances in pharmacology.

Synthesis and Pharmacological Evaluation of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a Cocaine Antagonist, in Rodents

B. Avery, Nidhi Kaushal, C. McCurdy, 2011, The AAPS Journal.

Discovery of TAK-041: a Potent and Selective GPR139 Agonist Explored for the Treatment of Negative Symptoms Associated with Schizophrenia.

H. Monenschein, A. Amador-Arjona, J. Bliesath, 2021, Journal of medicinal chemistry.

Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease

Justin Powell, H. Monenschein, S. Sheardown, 2021, The Journal of Pharmacology and Experimental Therapeutics.

Happiness at Work with Contentment: Enriching Workplace Well-Being Through Ancient Wisdom

Nidhi Kaushal, 2020, The Palgrave Handbook of Workplace Well-Being.

A Novel Substituted Piperazine, CM156, Attenuates the Stimulant and Toxic Effects of Cocaine in Mice

Yan-tong Xu, Nidhi Kaushal, C. McCurdy, 2010, Journal of Pharmacology and Experimental Therapeutics.

CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice

Nidhi Kaushal, C. McCurdy, C. Mesangeau, 2011, Neuropharmacology.

Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo

Nidhi Kaushal, C. McCurdy, R. Matsumoto, 2013, European Neuropsychopharmacology.